American Vanguard Corporation (AVD) - Total Liabilities
Based on the latest financial reports, American Vanguard Corporation (AVD) has total liabilities worth $475.62 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore AVD strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
American Vanguard Corporation - Total Liabilities Trend (1986–2025)
This chart illustrates how American Vanguard Corporation's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see AVD asset base.
American Vanguard Corporation Competitors by Total Liabilities
The table below lists competitors of American Vanguard Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alliance Aviation Services Ltd
AU:AQZ
|
Australia | AU$718.22 Million |
|
Vakrangee Limited
NSE:VAKRANGEE
|
India | Rs1.25 Billion |
|
3REN Berhad
KLSE:0328
|
Malaysia | RM23.84 Million |
|
Pungguk Ethanol Industrial Co. Ltd
KQ:023900
|
Korea | ₩30.60 Billion |
|
2S Metal Public Company Limited
BK:2S
|
Thailand | ฿330.83 Million |
|
Sherritt International Corporation
TO:S
|
Canada | CA$715.50 Million |
|
Agripure Holdings Public Company Limited
BK:APURE
|
Thailand | ฿512.45 Million |
|
Spirax Group plc
LSE:SPX
|
UK | GBX1.47 Billion |
Liability Composition Analysis (1986–2025)
This chart breaks down American Vanguard Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See American Vanguard Corporation balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how American Vanguard Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for American Vanguard Corporation (1986–2025)
The table below shows the annual total liabilities of American Vanguard Corporation from 1986 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $404.14 Million | +0.13% |
| 2024-12-31 | $403.61 Million | +1.53% |
| 2023-12-31 | $397.54 Million | +11.56% |
| 2022-12-31 | $356.33 Million | +10.86% |
| 2021-12-31 | $321.42 Million | +0.58% |
| 2020-12-31 | $319.56 Million | -7.89% |
| 2019-12-31 | $346.93 Million | +31.24% |
| 2018-12-31 | $264.36 Million | +14.80% |
| 2017-12-31 | $230.28 Million | +56.02% |
| 2016-12-31 | $147.60 Million | -15.76% |
| 2015-12-31 | $175.21 Million | -17.42% |
| 2014-12-31 | $212.17 Million | +11.87% |
| 2013-12-31 | $189.65 Million | +8.71% |
| 2012-12-31 | $174.45 Million | +14.72% |
| 2011-12-31 | $152.07 Million | +31.82% |
| 2010-12-31 | $115.36 Million | +13.52% |
| 2009-12-31 | $101.62 Million | -22.42% |
| 2008-12-31 | $130.99 Million | +20.35% |
| 2007-12-31 | $108.84 Million | -23.08% |
| 2006-12-31 | $141.50 Million | +40.41% |
| 2005-12-31 | $100.78 Million | +72.64% |
| 2004-12-31 | $58.37 Million | +3.50% |
| 2003-12-31 | $56.40 Million | +60.20% |
| 2002-12-31 | $35.20 Million | +1.73% |
| 2001-12-31 | $34.61 Million | -5.97% |
| 2000-12-31 | $36.80 Million | +24.72% |
| 1999-12-31 | $29.51 Million | -17.34% |
| 1998-12-31 | $35.70 Million | +5.31% |
| 1997-12-31 | $33.90 Million | +18.53% |
| 1996-12-31 | $28.60 Million | +34.27% |
| 1995-12-31 | $21.30 Million | -17.44% |
| 1994-12-31 | $25.80 Million | +14.67% |
| 1993-12-31 | $22.50 Million | +4.17% |
| 1992-12-31 | $21.60 Million | -3.57% |
| 1991-12-31 | $22.40 Million | +10.34% |
| 1990-12-31 | $20.30 Million | +86.24% |
| 1989-12-31 | $10.90 Million | +39.74% |
| 1988-12-31 | $7.80 Million | +11.43% |
| 1987-12-31 | $7.00 Million | +22.81% |
| 1986-12-31 | $5.70 Million | -- |
About American Vanguard Corporation
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection… Read more